Settlement Reached: Amyris Agrees to Pay Lavvan $15.1 Million
In a landmark decision, biotech company Amyris has agreed to pay cannabinoid manufacturer Lavvan a sum of $15.1 million, settling a lawsuit that accused Amyris of trade secret misappropriation and…
